NT-502

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNT-502
Drug Alias NameVGEF antagonist (Neurotech)NT-502
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGnt Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGnt Pharma
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A